Money from gene therapy

Gene therapy has taken far longer to reach fruition than companies orginally expected. But Megabios Corp. on Monday planned to announce that it has found a way to do make money in the area - by producing product for clinical trials.

MBIO (Burlingame, Calif.) and DSM Biologics N.V. (Groningen, the Netherlands) have partnered to manufacture plasmid DNA and lipid-DNA complexes in a three-year exclusive agreement. The deal allows MBIO, a product company, to leverage its in-house technology into the service sector before its gene-based products reach commercialization...